Bio-Path Holdings Company Profile (NASDAQ:BPTH)

About Bio-Path Holdings

Bio-Path Holdings logoBio-Path Holdings, Inc. is a clinical and preclinical stage oncology focused antisense drug development company. The Company utilizes a technology that achieves systemic delivery for target specific protein inhibition for any gene product that is over-expressed in disease. Its drug delivery and antisense technology, DNAbilize, is a platform that uses P-ethoxy, a deoxyribonucleic acid backbone modification. Its lead drug candidate, Liposomal Grb2 (BP1001), targets the protein Growth factor receptor-bound protein 2 (Grb2). Its other liposome delivered antisense drug candidate, Liposomal Bcl2 (BP1002), targets the protein B-cell lymphoma 2 (Bcl2). BP1001 is in Phase II clinical trials for acute myeloid leukemia, and for blast phase and accelerated phase chronic myelogenous leukemia. BP1002 is intended to target the lymphoma and certain solid tumor markets. BP1001 is also in preclinical studies for solid tumors, including triple negative breast cancer and inflammatory breast cancer.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Delivery
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: BPTH
  • CUSIP:
Key Metrics:
  • Previous Close: $1.36
  • 50 Day Moving Average: $1.55
  • 200 Day Moving Average: $2.09
  • 52-Week Range: $1.05 - $3.19
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -15.33
  • P/E Growth: 0.00
  • Market Cap: $130.08M
  • Outstanding Shares: 95,645,000
  • Beta: 1.52
Profitability:
  • Return on Equity: -77.03%
  • Return on Assets: -70.74%
Debt:
  • Current Ratio: 7.49%
  • Quick Ratio: 7.49%
Additional Links:
Companies Related to Bio-Path Holdings:

Analyst Ratings

Consensus Ratings for Bio-Path Holdings (NASDAQ:BPTH) (?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $3.50 (153.62% upside)

Analysts' Ratings History for Bio-Path Holdings (NASDAQ:BPTH)
Show:
DateFirmActionRatingPrice TargetDetails
8/11/2016Rodman & RenshawSet Price TargetBuy$5.00View Rating Details
8/10/2016Maxim GroupLower Price TargetBuy$5.00 -> $2.00View Rating Details
(Data available from 9/28/2014 forward)

Earnings

Earnings History for Bio-Path Holdings (NASDAQ:BPTH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/8/2016        
8/10/2016Q2($0.02)($0.02)ViewN/AView Earnings Details
5/11/2016Q1($0.01)($0.02)$2.33 millionViewListenView Earnings Details
3/15/2016Q4($0.01)($0.02)ViewN/AView Earnings Details
3/17/2015$0.01($0.02)ViewN/AView Earnings Details
11/18/2014($0.01)($0.01)ViewN/AView Earnings Details
8/18/2014Q214($0.01)($0.01)ViewN/AView Earnings Details
4/2/2014$0.01$0.01ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Bio-Path Holdings (NASDAQ:BPTH)
Current Year EPS Consensus Estimate: $-0.08 EPS
Next Year EPS Consensus Estimate: $-0.09 EPS

Dividends

Dividend History for Bio-Path Holdings (NASDAQ:BPTH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Bio-Path Holdings (NASDAQ:BPTH)
Insider Ownership Percentage: 13.13%
Institutional Ownership Percentage: 20.50%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/13/2015Michael J GarrisonDirectorBuy7,343$1.22$8,958.46View SEC Filing  
7/9/2015Michael J GarrisonDirectorBuy8,724$1.17$10,207.08View SEC Filing  
7/8/2015Michael J GarrisonDirectorBuy60,000$1.19$71,400.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Bio-Path Holdings (NASDAQ:BPTH)
DateHeadline
News IconPenny Stock Investors are Growing Curious About Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH)
www.duncanindependent.com - September 27 at 3:53 PM
News IconKeen Investors Find News on Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH)
www.duncanindependent.com - September 23 at 3:23 PM
News IconBio-Path Holdings's Buy Rating Reiterated at Maxim Group (BPTH) - Petro Global News 24 (NASDAQ:BPTH)
petroglobalnews24.com - September 23 at 9:00 AM
News IconUnder the Microscope, Zeroing in at Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH)
www.duncanindependent.com - September 23 at 9:00 AM
News IconPenny Stock Investors Keen on Shares of Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH)
www.duncanindependent.com - September 21 at 3:22 PM
News IconPenny Stock Investors Take an Interest in Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH)
www.duncanindependent.com - September 21 at 8:29 AM
News IconBio-Path Holdings Inc (BPTH) Given “Buy” Rating at Maxim Group - DailyQuint (NASDAQ:BPTH)
dailyquint.com - September 21 at 8:29 AM
News IconKeen Investors Seek Information on Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH)
www.duncanindependent.com - September 16 at 12:32 PM
News IconStock Update, a Closer Look at Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH)
www.duncanindependent.com - September 15 at 3:47 PM
News IconKeen Investors Narrowing Their Focus on Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH)
www.duncanindependent.com - September 14 at 3:56 PM
News IconPenny Stock Investors Highly Curious in Shares of Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH)
www.duncanindependent.com - September 13 at 5:50 PM
News IconGetting a Closer Look at Shares of Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH)
www.duncanindependent.com - September 12 at 3:50 PM
News IconMaking News: Targeting shares of Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH)
www.duncanindependent.com - September 10 at 8:39 AM
News IconFocusing the Spotlight on Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH)
www.duncanindependent.com - September 8 at 3:50 PM
News IconNarrowing the Lens on Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH)
www.duncanindependent.com - September 7 at 3:56 PM
globenewswire.com logoBio-Path Holdings to Present at the Rodman & Renshaw 18th Annual Global Investment Conference - GlobeNewswire (press release) (NASDAQ:BPTH)
globenewswire.com - September 6 at 8:53 PM
News IconOTC Investors Supremely Interested in Shares of Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH)
www.duncanindependent.com - September 6 at 8:53 PM
finance.yahoo.com logoBio-Path Holdings to Present at the Rodman & Renshaw 18th Annual Global Investment Conference (NASDAQ:BPTH)
finance.yahoo.com - September 6 at 8:47 AM
News IconA Second Look at Shares of Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH)
www.duncanindependent.com - September 2 at 3:46 PM
News IconTaking a Serious Look at Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH)
www.duncanindependent.com - September 1 at 12:24 PM
News IconUnder the Magnifying Glass: A Closer Look at Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH)
www.duncanindependent.com - September 1 at 12:24 PM
News IconZeroing Our Focus on Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH)
www.duncanindependent.com - August 30 at 11:46 AM
News IconPenny Stock Under the Microscope: Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH)
www.duncanindependent.com - August 26 at 12:00 PM
News IconOTC Investors Keen on Shares of Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH)
www.duncanindependent.com - August 26 at 12:00 PM
News IconLooking Closer at Stocks of Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH)
www.duncanindependent.com - August 25 at 8:50 AM
News IconLet's Take a Closer Look at Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH)
www.duncanindependent.com - August 23 at 8:06 AM
News IconStock Tracking Lower for the Quarter: Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Post News (NASDAQ:BPTH)
www.kentuckypostnews.com - August 21 at 8:38 AM
News IconSmall Cap Insight on Shares of Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH)
www.duncanindependent.com - August 20 at 3:56 PM
finance.yahoo.com logoBIO-PATH HOLDINGS INC Financials (NASDAQ:BPTH)
finance.yahoo.com - August 19 at 4:36 PM
News IconPenny Stock Alert - Update & Review on This Stock: Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH)
www.duncanindependent.com - August 19 at 12:18 PM
News IconA Closer Look at Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH)
www.duncanindependent.com - August 17 at 12:05 PM
News IconTaking A Closer Look at Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH)
www.duncanindependent.com - August 17 at 12:05 PM
News IconSmall Cap Update on: Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH)
www.duncanindependent.com - August 15 at 4:03 PM
cnbc.com logoBio-Path reports 2Q loss (NASDAQ:BPTH)
www.cnbc.com - August 10 at 9:24 PM
globenewswire.com logoBio-Path Holdings Reports Second Quarter 2016 Financial Results (NASDAQ:BPTH)
globenewswire.com - August 10 at 9:24 PM
seekingalpha.com logoBio-Path Holdings, Inc. (BPTH) CEO Peter Nielsen on Q2 2016 Results - Earnings Call Transcript (NASDAQ:BPTH)
seekingalpha.com - August 10 at 9:24 PM
seekingalpha.com logoBio-Path Holdings, Inc. (BPTH) CEO Peter Nielsen on Q2 2016 Results - Earnings Call Transcript - Seeking Alpha (NASDAQ:BPTH)
seekingalpha.com - August 10 at 3:23 PM
biz.yahoo.com logoBIO-PATH HOLDINGS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh (NASDAQ:BPTH)
biz.yahoo.com - August 10 at 3:23 PM
finance.yahoo.com logoBio-Path Holdings to Announce Second Quarter 2016 Financial Results on August 10, 2016 (NASDAQ:BPTH)
finance.yahoo.com - August 3 at 12:39 PM
biz.yahoo.com logoBIO-PATH HOLDINGS INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and Exh (NASDAQ:BPTH)
biz.yahoo.com - August 2 at 8:43 AM
News IconStock Displaying Signs of a Downtrend: Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Press Telegraph (NASDAQ:BPTH)
presstelegraph.com - July 23 at 3:53 PM
News IconBio Path Holdings DE (NASDAQ:BPTH) Shorted Shares Increased By 216.62% - Consumer Eagle (NASDAQ:BPTH)
www.consumereagle.com - July 19 at 3:57 PM
kcregister.com logoTop News: Bio-Path Holdings, Inc. (NASDAQ:BPTH), Great Basin Scientific, Inc. (NASDAQ:GBSN), Acasti Pharma Inc ... - KC Register (NASDAQ:BPTH)
www.kcregister.com - July 19 at 10:10 AM
ftsenews.co.uk logoBio-Path Holdings (BPTH) Updated Price Targets - FTSE News (NASDAQ:BPTH)
www.ftsenews.co.uk - July 19 at 10:10 AM
News IconShares Moving Down on the Week: Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Engelwood Daily (NASDAQ:BPTH)
www.engelwooddaily.com - July 17 at 3:47 PM
News IconShares Experiencing a Downtrend: Bio-Path Holdings, Inc. (NASDAQ:BPTH) - TGP (NASDAQ:BPTH)
telanaganapress.com - July 16 at 8:28 AM
News IconShare Volatility Watch for: Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Engelwood Daily (NASDAQ:BPTH)
www.engelwooddaily.com - July 13 at 12:02 PM
News IconBio-path Holdings Inc (NASDAQ:BPTH) Sentiment Change Report - Consumer Eagle (NASDAQ:BPTH)
www.consumereagle.com - July 13 at 12:02 PM
finance.yahoo.com logoBio-Path Holdings to Present at the 2nd Annual Cantor Fitzgerald Healthcare Conference (NASDAQ:BPTH)
finance.yahoo.com - July 6 at 8:00 AM
bizjournals.com logoHouston biotech firm collaborates with university on brain cancer therapy (NASDAQ:BPTH)
www.bizjournals.com - July 5 at 3:57 PM

Social

Bio-Path Holdings (NASDAQ:BPTH) Chart for Wednesday, September, 28, 2016


Last Updated on 9/28/2016 by MarketBeat.com Staff